newsfilter
← Latest News
PR Newswire·

New Research Demonstrates Thymosin Beta 4's Potential Positive Effects on Alzheimer's Disease

ROCKVILLE, Md., Oct. 5, 2021 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB:RGRX) ("RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration), today announced that a new research paper was pub